Immunoassays

The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

Cardiolipin-Check is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the combined quantitative detection of IgA, IgG and IgM antibodies against cardiolipin in human serum.

Cardiolipin-GM is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the quantitative detection of IgG and /or IgM vantibodies against cardiolipin in human serum.

β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2-glycoproteinI highly purified from human plasma for the separate quantitative detection of IgG and / or IgM antibodies against β2-glycoprotein I in human serum.

Phospholipid-Screen-GM is a solid phase enzyme immunoassay for the separate quantitative detection of IgG and/or IgM antibodies against phospholipids in human serum. Each well is coated with highly purified bovine cardiolipin + ß2-glycoprotein I, phosph.

ANCA Pro is a solid phase enzyme immunoassay employing highly purified native myeloperoxidase (MPO) and proteinase 3 (PR3) from human peripheral blood polymorphnuclear cells and native human Cathepsin G, Elastase, Lactoferrin, Lysozym and BPI.

PR3 sensitive is a solid phase enzyme immunoassay employing highly purified native human proteinase 3 (PR3) from human neutrophil granulocytes for the quantitative detection of antibodies against proteinase 3 in human serum.

MPO is a solid phase enzyme immunoassay employing highly purified native myeloperoxidase (MPO) from human peripheral blood polymorphnuclear cells for the quantitative detection of antibodies against MPO in human serum.

GBM is a solid phase enzyme immunoassay employing recombinant human glomerular basement membrane protein (GBM) for the quantitative detection of IgG antibodies against GBM in human serum. The assay is an aid in the diagnosis of Goodpasture syndrome.